NUVL Prakiraan wutah bathi resik saben saham kanggo taun ngarep nuvalent.com

Logo korporat perusahaan Nuvalent Therapeutics (NUVL)

Nuvalent, Inc. (NUVL) develops unique kinase inhibitors to combat tumor resistance, utilizing a strict cold chain for drug delivery. The projected n+1 net profit growth rate visualizes these technological advantages, with the indicator level standing at 18.20. Business stability is supported by significant cash reserves that fully cover the costs of current clinical trials.

NUVL: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nuvalent Inc 04.07.2022 - 25.07.2026

Rincian metrik keuangan lan pasar Nuvalent (NUVL)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Nuvalent, NUVL
Produk merek nuvalent.com

Defensive assets are selected based on their ability to maintain margins amid market volatility, which is evidenced by Nuvalent, Inc. (NUVL) and its commitment to bioethical principles and the minimization of chemical costs in the development of targeted drugs. The consensus growth forecast for the upcoming period, reflected through the expected EPS dynamics for next year on GURU.Markets, measures the rate of change in future earnings, allowing investors to assess the business's financial stability and the risks of excessive leverage.

Perusahaan pesaing

GMAB (Genmab Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep exelixis.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ELVN (Enliven Therapeutics Inc)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep ORIC Pharma|Relay Therapeutics Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VSTM: Proyeksi tambahing bathi saben saham ing taun ngarep|GLUE (monterosatx.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cullinan Therapeutics Inc CGEM|Prakiraan wutah bathi kanggo taun ngarep IMRX|C4 Therapeutics - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Black Diamond Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPTX|PMVP: Prakiraan wutah bathi saben saham kanggo taun ngarep|karyopharm.com - Proyeksi tambahing bathi saben saham ing taun ngarep|PPCB: Prakiraan wutah bathi kanggo taun ngarep|Bio Green Med Solution Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep aileronrx.com ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks Therapeutics, Inc)